AI risk use-case mapping
Review the repeated task, competing approaches, required evidence and suitable validation test without treating an unbuilt product as launched.
Discuss a scoped briefMake failure cases reproducible, decisions traceable and human oversight visible. An organization cannot reliably document and retest AI output errors or oversight decisions.

An organization cannot reliably document and retest AI output errors or oversight decisions.
Assess AI test-case libraries and risk-evidence registers with defined tasks, acceptance rubrics, exception routing and human sign-off. The first responsible step is to document a measurable buyer question and the limitations of the evidence already available. The first question is whether the repeated task is real, safe and suitable for reuse. A service can review a product idea before software exists.
These are possible product families. No downloadable kit, live diagnostic, enrolled course, active platform or subscription is represented as currently available.
Current difficulty: An organization cannot reliably document and retest AI output errors or oversight decisions.
Proposed response: Assess AI test-case libraries and risk-evidence registers with defined tasks, acceptance rubrics, exception routing and human sign-off.
Useful result: An evidence-based product-feasibility decision with a suitable prototype or advisory pathway, not access to released software.
Before work begins, confirm source access, affected stakeholders, a proportionate research method and what a negative result would mean. That prevents a polished narrative from being confused with a tested service or market outcome.
The following are scopes for discussion, not fixed deliverables or claims about outcomes already achieved. The exact question, authorized access and evidence needed determine the appropriate engagement.
Review the repeated task, competing approaches, required evidence and suitable validation test without treating an unbuilt product as launched.
Discuss a scoped briefReview the repeated task, competing approaches, required evidence and suitable validation test without treating an unbuilt product as launched.
Discuss a scoped briefReview the repeated task, competing approaches, required evidence and suitable validation test without treating an unbuilt product as launched.
Discuss a scoped briefA scoped brief should specify the question, relevant sources, sample and geography, reviewer, acceptance criteria and important exclusions.
Combine a clear business problem, defensible comparison criteria, accurate source attribution, practical execution knowledge and a human reviewer. Separate a research finding from a commercial claim; neither a high-level market statistic nor a product-concept drawing verifies a successful client outcome.
These are possible product families. No downloadable kit, live diagnostic, enrolled course, active platform or subscription is represented as currently available. A specialist assessment should identify which claims can be supported, what a real pilot would demonstrate and which permissions or professional referrals are necessary.
External references document published standards, methods or market indicators. They do not establish that the proposed product exists, that a market has been won, or that any named institution endorses this service.
Use dated publications and define statistical scope when citing results. A corporate website, official programme, regulatory guidance and peer-reviewed finding have different evidentiary meanings.
Discover: agree the precise buyer task and intended decision. Verify: collect legitimate, dated evidence and record gaps. Compare: evaluate alternative approaches on a consistent method. Decide: prepare a reviewable conclusion, limitations and a next-step or no-go recommendation.
Every deliverable should be independently useful, with a source list, data definition, reviewer, correction route and an explicit statement of what remains uncertain. Discuss the evidence and intended use.
Design AI evaluation and risk records before offering assurance software. Assess AI test-case libraries and risk-evidence registers with defined tasks, acceptance rubrics, exception routing and human sign-off. A useful first decision is whether repeatable work has been demonstrated with real users, sufficient rights and a responsible review process. A concept can be valuable as a research brief even when building a permanent software product is not warranted.
These are categories for comparing approaches, not a directory of verified suppliers or currently available MRD applications. The unit of comparison is the buyer task, necessary proof and the human responsibility that remains after a trial. Market and country availability must be checked separately with actual providers.
| Potential model or use case | What it would help assess | Important qualification |
|---|---|---|
| Output test-case library | Record expected behavior and grading criteria for named tasks. | Good averages may conceal consequential failures. |
| Risk evidence vault | Store reviewed decisions and supporting documentation. | Records without ownership or versioning. |
| Human approval register | Document who authorized an action and with what constraints. | Approvals performed after the event. |
| Re-testing workflow | Run relevant scenarios after models, prompts or data change. | Uncontrolled drift and incomplete regression suites. |
An AI assistant summarizing a public article has a different risk profile from a system classifying confidential client records or changing a customer account. An assurance product cannot be assessed without user role, decision impact, available data and the consequence of failure. Document prohibited operations and conditions that must trigger human review before choosing scoring metrics.
Evaluation requires examples of ordinary inputs, ambiguous requests, missing context, incorrect sources, malicious instructions and boundary cases. An aggregate groundedness score may conceal a small set of damaging mistakes. A useful library preserves test data provenance, expected outcomes, human adjudication notes and the version of the system under test.
A portal storing prompts, model outputs and incident notes may itself become sensitive. Apply least privilege and defined retention rather than keeping everything for convenience. Records should distinguish a suggested policy, a tested control and a documented organizational approval. These are different levels of assurance and should not be presented as equivalent.
NIST AI RMF organizes risk work under Govern, Map, Measure and Manage. It does not mean that referencing its functions certifies a particular tool or satisfies all legal obligations. The same is true of OWASP application-risk taxonomy: a completed checklist cannot replace scoped technical testing and review.
A model update, revised prompt, newly connected document collection or changed user role can invalidate earlier evaluation. The prototype should support test replays, exceptions, approval ownership and a dated decision to accept, improve, pause or discontinue the use case. If the operating environment cannot support that continuity, a periodic independent assessment may be more credible than a persistent product.
Technical approaches, usage rights and professional obligations vary across markets. A source suitable for one kind of work should not be treated as proof of another. For a cross-border project, record the market, language, content or data rights, relevant platform rules and who is authorized to review the resulting decision.
A choice among manual research, approved existing software, a managed professional service and a bespoke product should be made using the same scoped task. Record which alternatives have actually been tested, rather than giving an unreviewed concept an automatic advantage.
| Approach | When it can fit | Validation needed |
|---|---|---|
| Manual risk register | Small set of scoped AI uses | Named owner and revision date |
| Test-case workbook | Repeated answers requiring review | Expected result and grading rubric |
| Evaluation pipeline | Frequent changes and repeatable tests | Versioning and independent spot checks |
| Assurance portal concept | Larger governed processes | Access, retention and auditability |
The calculations below are proposed research measures, not published outcomes. Use a fixed test period and a documented sample; where the denominator is zero or unavailable, mark the measure unavailable instead of replacing it with an invented percentage.
These seven tests are practical screening questions. A failed test may mean the proposed product should remain a supervised service, be redesigned, or not proceed.
Product boundary: Discussed product types are hypotheses for advisory evaluation, not downloadable tools, live subscriptions, installed client systems or verified performance claims. The public offer is a scoped feasibility discussion.
Request examples of the actual workflow, relevant user roles and source rights before deciding what can be evaluated. Any future software release would require separate performance, privacy, accessibility, ownership, acceptance and maintenance checks. Evidence of use-case interest should not be confused with guaranteed adoption, search results or revenue.
Related pathways: all services, digital platforms and research intelligence. Discuss a scoped feasibility review.
These links provide access to separate research and professional websites. They do not imply sponsorship, endorsement, agency or a verified commercial partnership.
Describe the buyer role, geography or system involved, the sources already available and what you need to decide. A scoped assessment can show whether further action is justified.
Request a Product Feasibility Review